Using amniotic membrane therapy to treat interstitial cystitis and painful bladder syndrome
Official title: Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-Blind, Randomized Controlled Trial
Run by University Hospitals Cleveland Medical Center · NCT06096597 · Data updated 2026-11-12
This study is testing whether injections of amniotic membrane therapy can help people with interstitial cystitis and painful bladder syndrome feel less pain and improve their urinary symptoms.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospitals Cleveland Medical Center Academic / other |
| Locations | 1 site (Clevleand, Ohio) |
| Status | Recruiting |
| Started | July 24, 2024 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT06096597 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are English-speaking females aged 18 and older who have been diagnosed with IC/PBS and have not responded to at least one prior treatment.
✕Probably not a fit
Patients under 18 years of age, non-English speakers, or those with anatomical malformations of the urinary tract may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of amniotic membrane therapy in patients suffering from interstitial cystitis/painful bladder syndrome (IC/PBS). The study will involve administering intradetrusor injections of Clarix FLO™, a micronized amniotic membrane, to assess improvements in bladder pain and urinary symptoms. Participants will be monitored for clinically significant changes using validated symptom questionnaires. This trial represents the first randomized controlled trial of this innovative treatment approach for IC/PBS.
Why it matters
Potential benefit: If successful, this therapy could provide significant relief from bladder pain and urinary symptoms for patients with IC/PBS.
How similar studies have gone: While preliminary studies have shown promising results with amniotic membrane therapy for bladder conditions, this is the first randomized controlled trial assessing its efficacy for IC/PBS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age or older * Female * English Speaking * Diagnosis of IC/PBS * Have failed at least one prior treatment for IC/PBS Exclusion Criteria: * Patients less than 18 years of age * Unable to provide consent * Non-English speaking * Patients with known anatomical malformations of the ureters, bladder, or urethra
Where it's running
-
University Hospitals
Clevleand, Ohio, United States Recruiting
Study contacts
- Principal investigator: David Sheyn, MD — University Hospitals Cleveland Medical Center
- Study coordinator: Diana Mitchell, MD
- Email: diana.mitchell@uhhospitals.org
- Phone: (216) 844-3009
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aerobic Exercise and Massage for Painful Bladder Syndrome in Women
This study tests whether adding aerobic exercise and connective tissue massage to patient education helps reduce bladder pain and improve symptoms for women with bladder pain syndrome.
-
Assessing pain types in treating bladder pain syndrome
This study is trying to see how different types of bladder pain affect how well people with bladder pain syndrome respond to pelvic floor physical therapy and cognitive-behavioral therapy.
-
Impact of preoperative immunonutrition on recovery after bladder surgery
This study tests if special nutritional drinks before bladder surgery can help patients recover better and have fewer complications afterward.
-
Genetic analysis of chronic pelvic pain conditions
This study is trying to find out if certain genes are linked to chronic pelvic pain by collecting samples from people with the condition and their families.
-
Evaluating a catheter-free method for bladder medication delivery
This study is testing a new way to deliver bladder medication without a catheter to see if it’s more comfortable and safer for people with conditions like interstitial cystitis and recurrent urinary tract infections.
-
Treatment of bladder pain using VNX001
This study is testing a new treatment called VNX001 to see if it can help people with moderate to severe bladder pain feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.